908 DevicesMASS
About: 908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
Employees: 246
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
45% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
5.61% less ownership
Funds ownership: 53.73% [Q3] → 48.12% (-5.61%) [Q4]
6% less funds holding
Funds holding: 86 [Q3] → 81 (-5) [Q4]
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
43% less capital invested
Capital invested by funds: $64.8M [Q3] → $36.9M (-$27.9M) [Q4]
97% less call options, than puts
Call options by funds: $2K | Put options by funds: $66K
Research analyst outlook
We haven’t received any recent analyst ratings for MASS.
Financial journalist opinion
Based on 5 articles about MASS published over the past 30 days
